How to Avoid The Dangers of Duplicate Participants in Clinical Trials
The prevalence of duplicate participants in clinical trials poses significant risks, compromising the integrity of data and the safety...
The prevalence of duplicate participants in clinical trials poses significant risks, compromising the integrity of data and the safety...
Clinical trials in liver stem cell transplantation therapy represent a frontier in medical research, particularly for conditions like late-stage...
In this interview, Michael Torok, Head of Quality Assurance Programs at Roche, delves into the operationalization of RBQM (Risk...
In this exclusive interview, we sit down with Donna Libretti Cooke, JD, a distinguished clinical operations specialized consultant known...
In an era in which the White House Office of Science and Technology Policy emphasizes the need for a...
In today’s interview, we’re speaking with Dr. In-seok Park, Ph.D., the esteemed President of KoNECT. Dr. Park, who assumed...
In this interview with Gian Carlo (GC) Ochoa, a leading figure in digital twins technology for clinical trials, we...
In this interview, we spoke with Joey Bose, President & CEO of Cytonics, diving into the intricacies of their...
In today’s discussion, we’re joined by Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance (DTRA), who shares...
Dive into the forefront of clinical trial innovation with our interview featuring Anthony Costello from Medidata. We discuss groundbreaking...